Dr. Howard Koh is stepping down as assistant secretary for health at HHS after five years in the post. Koh's primary focus was disease prevention, including oversight of the Office of the Surgeon General.
Dr. Howard Koh is stepping down as assistant secretary for health at HHS after five years in the post. Koh's primary focus was disease prevention, including oversight of the Office of the Surgeon General.
Koh is returning to the faculty of the Harvard School of Public Health, where he taught before joining the Obama administration. He will depart at the end of July, according to HHS. Dr. Wanda Jones, who serves as principle deputy assistant secretary for health, will take over his duties until a replacement is named.
“Howard's broad range of accomplishments at HHS reflects his deep passion for promoting public health in so many arenas,” HHS Secretary Sylvia Mathews Burwell wrote in an internal message announcing his resignation. “He was the primary architect of landmark HHS strategic plans on tobacco control, health disparities and chronic viral hepatitis that will leave a legacy for many years.”
Read the full story here: http://bit.ly/1rbQkiR
Source: Modern Healthcare
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More